Australia markets open in 3 hours 22 minutes

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0256+0.0009 (+3.73%)
As of 09:46AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.0247
Open0.0256
BidN/A x N/A
AskN/A x N/A
Day's range0.0256 - 0.0256
52-week range0.0100 - 0.2080
Volume25,000
Avg. volume24,211
Market cap1.513M
Beta (5Y monthly)0.53
PE ratio (TTM)N/A
EPS (TTM)-0.1060
Earnings date28 Oct 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Ehave Shareholder from CEO Ben Kaplan and Corporate Update

    MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan. Dear Fellow Shareholders As 2022 draws to a close, many of us will reflect on a year that saw global economic activity experiencing a broad-based and sharper-than-expected slowdown, increased inflation higher than we have seen in seve

  • GlobeNewswire

    Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research

    AI-driven discovery platform enables new way to find novel pathways, as well as progress towards identifying patients who may better respond to drugs in the clinicGenetic test kit evaluates an individual's overall sensitivity and risk profile associated with psychedelic-assisted therapy MIAMI, June 01, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will begin using precision med